Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?

Item

http://www.wikidata.org/entity/Q44699631

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Clinical, echocardiographic, a ...... apy: are they interchangeable?

@en

Clinical, echocardiographic, a ...... apy: are they interchangeable?

@nl

type

Item

label

Clinical, echocardiographic, a ...... apy: are they interchangeable?

@en

Clinical, echocardiographic, a ...... apy: are they interchangeable?

@nl

prefLabel

Clinical, echocardiographic, a ...... apy: are they interchangeable?

@en

Clinical, echocardiographic, a ...... apy: are they interchangeable?

@nl

P1476

Clinical, echocardiographic, a ...... apy: are they interchangeable?

@en

P2093

Dominique Auger

http://www.w3.org/2001/XMLSchema#string

Eduard R Holman

http://www.w3.org/2001/XMLSchema#string

Georgette E Hoogslag

http://www.w3.org/2001/XMLSchema#string

Harriette F Verwey

http://www.w3.org/2001/XMLSchema#string

Joep Thijssen

http://www.w3.org/2001/XMLSchema#string

Martin J Schalij

http://www.w3.org/2001/XMLSchema#string

Ron Wolterbeek

http://www.w3.org/2001/XMLSchema#string

Ulas Höke

http://www.w3.org/2001/XMLSchema#string

Victoria Delgado

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy.

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

State of the art: using natriuretic peptide levels in clinical practice.

Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective.

Treatment options in end-stage heart failure: where to go from here?

Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.

Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

P304

1391-1401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PACE.12214

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeroen Joost Bax

Nina Ajmone Marsan

P577

2013-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23826659

http://www.w3.org/2001/XMLSchema#string

P921

echocardiography